Dalamax Special Precautions

If diarrhea or colitis develops, treatment with clindamycin should be discontinued. Clindamycin should also be used with caution in atopic patients.
Use in patients with renal and hepatic impairment: Caution must be taken when giving clindamycin to patients with renal and hepatic impairment. Adjustment of the dosage is required.
Blood counts, renal and liver function should be monitored in patients receiving prolonged treatment of clindamycin.
Use in pregnancy: US FDA CATEGORY B. Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women or Animal studies which have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.
Clindamycin is found to diffuse across the placenta and into the fetal circulation. It should therefore be used with caution in pregnant patients.
Use in lactation: Clindamycin is excreted in the breast milk. Breastfeeding should be avoided when taking the drug.
Use in infants and children: Blood counts, renal and liver function should be monitored in infants and children taking clindamycin.
Use in elderly: Renal and liver function should be monitored in the elderly being treated with clindamycin. Elderly patients should be monitored for any changes in the frequency of bowel movement or development of diarrhea.